ArticleCancer discovery2018

Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy.

Harinad B Maganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.